In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens

Acta Tropica

Volumn 88, Issue 2, 2003, Pages 117-130

  Al Sherbiny, Maged ^a   Osman, Ahmed ^a   Barakat, Rashida ^b   El Morshedy, Hala ^b   Bergquist, Robert ^c   Olds, Richard ^d  

^a CAIRO UNIVERSITY   (Egypt)

^b High Institute of Public Health Egypt   (Egypt)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cytokine response; Resistance to re infection; Schistosomiasis; Vaccine

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; MAP3 ANTIGEN; MAP4 ANTIGEN; PARASITE ANTIGEN; PL45 PHOSPHOGLYCERATE KINASE ANTIGEN; PN 18 CYCLOPHILIN ANTIGEN; PR52 FILAMIN ANTIGEN; PRAZIQUANTEL; RECOMBINANT ANTIGEN; SCHISTOSOMA VACCINE; SM14 FABP ANTIGEN; SM28 GST ANTIGEN; SM37 G3PDH ANTIGEN; SM62 IRV5 ANTIGEN; SM97 PARAMYOSIN ANTIGEN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

DRUG RESISTANCE; PERFORMANCE ASSESSMENT; SCHISTOSOMIASIS; VACCINATION;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG SCREENING; EGYPT; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TECHNIQUE; IN VITRO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PARASITOLOGY; REINFECTION; RESIDENT; RETROSPECTIVE STUDY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SEROLOGY; VACCINATION;

ANIMALIA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0141679044     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00195-5     Document Type: Article

References (54)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383(6603):1996;787-793.
2. Acosta L.P., Aligui G.D., Tiu W.U., McManus D.P., Olveda R.M. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines. I. Assessment of 'resistance' versus 'susceptibility' to S. japonicum infection. Acta Trop. 84(2):2002;127-136.
3. Bergquist N.R. Schistosomiasis vaccine: an update. TDR News. 50:1996;8-9.
4. Bergquist N.R. Schistosomiasis vaccine development: progress and prospects. Mem. Inst. Oswaldo Cruz. 93(Suppl. 1):1998;95-101.
5. Bergquist N.R., Colley D.G. Schistosomiasis vaccines: research to development. Parasitol. Today. 14(3):1998;99-104.
6. Boom W.H., Liani D., Abbas A.K. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J. Exp. Med. 167(4):1988;1350-1363.
7. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Med. 21:1968;77-81.
8. Brito C.F., Fonseca C.T., Goes A.M., Azevedo V., Simpson A.J., Oliveira S.C. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14 kDa fatty acid-binding recombinant protein. Parasite Immunol. 22(1):2000;41-48.
9. Butterworth A.E., Capron M., Cordingley J.S., Dalton P.R., Dunne D.W., Kariuki H.C., Kimani G., Koech D., Maugambi M., Ouma J.H., Richadson B.A., Arap Siongok T.K., Sturrock R.F., Taylor D.W. Immunity after treatment of human schistosomiasis. II. Identification of resistant individuals, and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79:1985;393-408.
10. Butterworth A.E., Dunne D.W., Fulford A. Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 antibodies block the expression of immunity. Biochimie. 70:1988;1053-1063.
11. Butterworth A.E., Dunne D.W., Fulford A.J., Ouma J.H., Sturrock R.F. Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects. Am J. Trop. Med. Hyg. 55(Suppl. 5):1996;109-115.
12. Caldas I.R., Correa-oliveira R., Colosimo E., Carvalho O.S., Massara C.L., Colley D.G., Gazzinelli G. Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am. J. Trop. Med. Hyg. 62(1):2000;57-64.
13. Capron A., Dessaint J.P., Capron M., Ouma J.H., Butterworth A.E. Immunity to schistosomes: progress toward a vaccine. Science. 238:1987;1065-1072.
14. Capron A., Riveau G., Grzych J.M., Boulanger D., Capron M., Pierce R. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Immunity to schistosomes: progress toward a vaccine. Mem. Inst. Oswaldo Cruz. 90(2):1995;235-240.
15. Capron A., Capron M., Dombrowicz D., Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int. Arch. Allergy Immunol. 124(1-3):2001;9-15.
16. Carabin H., Guyatt H., Engels D. A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi. Trop. Med. Int. Health. 5(3):2000;192-202.
17. Cheever A.W., Hoffmann K.F., Wynn T.A. Immunopathology of schistosomiasis mansoni in mice and men. Immunol. Today. 21(9):2000;465-466.
18. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Trop. 77:2000;41-51.
19. Dalton J.P., Strand M. Schistosoma mansoni polypeptides immunogenic in mice vaccinated with radiation-attenuated cercariae. J. Immunol. 139(7):1987;2474-2481.
20. Davis A., Wegner D.H. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull. World Health Organ. 57(5):1979;767-771.
21. Dean D.A. A REVIEW Schistosoma and related genera: acquired resistance in mice. Exp. Parasitol. 55:1983;1-104.
22. Demeure E.C., Rihet P., Abel L., Ouattara M., Bourgois A., Dessein A.J. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168:1993;1000-1009.
23. Dessein A.J., Begley M., Demeure C., Caillol D., Fueri J., Dos Reis M.G., Andrade Z.A., Prata A., Bina J.C. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
24. El Ridi R., Farouk F., Sherif M., Al-Sherbiny M., Osman A., El Gengehi N., Shoemaker C.B. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium. J. Infect. Dis. 177(5):1998;1364-1372.
25. El Ridi R., Mahrous A., Afifi A., Montash M., Velek J., Jezek J. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to schistosomiasis. Scand. J. Immunol. 54:2001;477-482.
26. Fulford A.J.C., Webster M., Ouma J.H., Kimani G., Dunne D.W. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today. 14(1):1998;23-26.
27. Goudot-Crozel V., Caillol D., Djabali M., Dessein A.J. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37 kDa glyceraldehyde-3P-dehydrogenase. J. Exp. Med. 170:1989;2065-2080.
28. Grogan J.L., Kremsner P.G., van Dam G.J., Metzger W., Mordmuller B., Deelder A.M., Yazdanbakhsh M. Anti-schistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J. Infect. Dis. 173:1996;1242-1247.
29. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J., Wilkins H.A. Human IgE, IgG4 and resistance of reinfection with Schistosoma haematobium. Nature. 349:1991;243-245.
30. Hancock K., Tsang V.C.W. Development and optimization of the FAST ELISA for detecting antibodies to S. mansoni. J. Immunol. Methods. 92:1986;167-176.
31. Harn D.A., Gu W., Oligino L.D., Mitsuyama M., Gerbremichael A., Richter D. A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase. J. Immunol. 148:1992;562-567.
32. Harn D.A., Reynolds S.R., Chikunguwo S., Furlong S., Dahl C. Synthetic peptide vaccines for schistosomiasis. Pharm. Biotechnol. 6:1995;891-905.
33. Hawn T.R., Strand M. Developmentally regulated localization and phosphorylation of SmIrV1, a schistosoma mansoni antigen with similarity to calnexin. J. Biol. Chem. 269(31):1994;20083-20089.
34. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J. Trop. Med. Hyg. 60(6):1999;932-935.
35. James S.L., Salzman C., Pearce E.J. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by non-responder mouse strains. Parasite Immunol. 10(1):1988;71-83.
36. Kabatereine N.B., Vennervald B.J., Ouma J.H., Kemijumbi J., Butterworth A.E., Dunne D.W., Fulford A.J. Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology. 118:1999;101-105.
37. Lee K.W., Thakur A., Karim A.M., LoVerde P.T. Immune response to Schistosoma mansoni phosphoglycerate kinase during natural and experimental infection: identification of a schistosome-specific B-cell epitope. Infect. Immun. 63(11):1995;4307-4311.
38. London C.A., Abbas A.K., Kelso A. Helper T cell subsets: heterogeneity, functions and development. Vet. Immunol. Immunopathol. 63(1-2):1998;37-44.
39. Nara T., Tanabe K., Mahakunkijcharoen Y., Osada Y., Matsumoto N., Kita K., Kojima S. The B cell epitope of paramyosin recognized by a protective monoclonal IgE antibody to Schistosoma japonicum. Vaccine. 15(1):1997;79-84.
40. Naus C.W., Kimani G., Ouma J.H., Fulford A.J., Webster M., Van Dam G.J., Deelder A.M., Butterworth A.E., Dunne D.W. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect. Immun. 67(7):1999;3444-3451.
41. Ouma J.H., Fulford J.C., Kariuki H.C., Kimani G., Sturrock R.F., Muchemi G., Butterworth A.E., Dunne D.W. The development of schistosomiasis mansoni in an immunologically naïve immigrant population in Masongaleni, Kenya. Parasitology. 117:1998;123-132.
42. Pearce E.J., James S.L., Heing S., Lanar D., Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a non-surface parasite antigen. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5678-5682.
43. Reich M.R., Govindaraj R. Dilemmas in drug development for tropical diseases. Experiences with praziquantel. Health Policy. 44(1):1998;1-18.
44. Reynolds S.R., Shoemaker C.B., Harn D.A. T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni. J. Immunol. 149:1992;3995-4001.
45. Ribeiro De Jesus A., Araújo I., Bacellar O., Magalhães A., Pearce E., Harn D., Strand M., Carvalho E.M. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect. Immun. 68(5):2000;2797-2803.
46. Richter D., Harn D.A. Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni. Infect. Immun. 61(1):1993;146-154.
47. Shoemaker C., Gross A., Gebremichael A., Harn D.A. cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1842-1846.
48. Soisson L.A., Strand M. Schistosoma mansoni: induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen. Exp. Parasitol. 77(4):1993;492-494.
49. Soisson L.M., Masterson C.P., Tom T.D., McNally M.T., Lowell G.H., Strand M. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J. Immunol. 149(11):1992;3612-3620.
50. Taylor J.B., Vidal A., Torpier G., Meyer D.J., Roitsch C., Balloul J.M., Southan C., Sondermeyer P., Pembel S., Lecocq J.P., Capron A., Ketterer B. The glutathione transferase activity and tissue distribution of a cloned Mr 28K protective antigen of Schistosoma mansoni. EMBO J. 7:1988;465-472.
51. Tendler M., Brito C.A., Vilar M.M., Serra Freire N., Diogo C.M., Almeida M.S., Delbem A.C., Da Silva J.F., Savino W., Garratt R.C., Katz N., Simpson A.S. A Schistosoma mansoni fatty-acid binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. U.S.A. 93(1):1996;269-273.
52. WHO, 1985. The control of schistosomiasis. Report of a WHO Expert Committee. WHO Technical Report Series 728. The World Health Organization, Geneva, 113 pp.
53. WHO, 1993. The control of schistosomiasis. Second Report of the WHO Expert Committee. WHO Technical Report Series 830. The World Health Organization, Geneva, 86 pp.
54. Wilkins H.A., Blumenthal V.J., Hagan P., Heyes R.J., Tulloch S. Resistance to reinfection after treatment of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 81:1987;29-35.